Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma. - Takizawa, Daichi; Arai, Hirotaka; Shibasaki, Mitsuhiko; Tamura, Yuki; Kakizaki, Satoru; Hatanaka, Takeshi; Naganuma, Atsushi; Ueno, Takashi; Fukuchi, Toru; Namikawa, Masashi; Takakusagi, Satoshi; Saito, Shuichi; et al. (Current Oncology, 2026)